Table 2.
Demographic characteristics, ultrasound findings, percentage of vascular risk factors and the median HAD2S score at baseline for each group (non-progression vs. progression).
| Non-Progression N = 254 |
Progression N = 86 |
p Value | |
|---|---|---|---|
| Follow up, months (median, IQR) | 36.2 (5.2) | 37.2 (6.5) | 0.104 |
| Age, years (mean, SD) | 69.2 (9.2) | 71.9 (8.4) | 0.012 |
| Sex (n, % of males) | 126 (49.6) | 50 (58.1) | 0.212 |
| Risk factors, n (%) | |||
| Hypertension | 201 (79.1) | 74 (86.0) | 0.204 |
| Hyperlipidemia | 179 (70.5) | 59 (68.6) | 0.786 |
| Diabetes | 54 (21.3) | 25 (29.1) | 0.142 |
| Smoking | 32 (12.6) | 13 (15.1) | 0.582 |
| Ultrasound findings * | |||
| IMT (mean, SD) | 0.77 (0.18) | 0.86 (0.17) | <0.001 |
| Right ICA PSV (median, IQR) | 85 (38) | 93 (44) | 0.063 |
| Right ICA EDV (median, IQR) | 26 (15) | 26 (11) | 0.808 |
| Left ICA PSV (median, IQR) | 88 (39) | 95.5 (46) | 0.036 |
| Left ICA EDV (median, IQR) | 27 (13) | 27 (15) | 0.822 |
| HAD2S score | 2 (1) | 3 (1) | 0.032 |
* At T3, 86 (25.3%) subjects had plaque progression; of these, 34 (10.0%) in the left side, 39 (11.5%) in the right side and 13 (3.85%) bilaterally.